I hope all of the organizations pushing this treatment collaborate.

“Kyoto is going to be starting in this month, and in coming months we hope to hear about the commencement of a US-based clinical study being conducted by a biotech company called BlueRock Therapeutics.

In addition, there is the on going Transeuro study testing the fetal transplantation approach for Parkinson’s.

And there is a cell transplantation clinical study being conducted in Melbourne (Australia), by an American company called International Stem Cell Corporation.

So all-in-all, there is a great deal of research activity on the cell replacement therapy front. And this is very encouraging to see after a long period of high hopes for this therapeutic approach.”